Skip to main content

Table 3 Percentage of FN and FP rates according to value risk categories are reported

From: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase

Risk Categories

11%

20%

30%

45%

50%

31%

% False negative (FN)

1%

3.5%

8.2%

18.4%

24.4%

8.9%

% False positive FP)

56.0%

45.6%

31.4%

15.6%

9.0%

30.1%